Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Business and Significant Accounting Policies (Details)

v3.3.0.814
Note 1 - Nature of Business and Significant Accounting Policies (Details)
3 Months Ended
Apr. 29, 2015
shares
Dec. 10, 2014
shares
Nov. 12, 2014
shares
Aug. 31, 2015
USD ($)
Aug. 31, 2014
USD ($)
May. 31, 2015
USD ($)
May. 31, 2014
USD ($)
Note 1 - Nature of Business and Significant Accounting Policies (Details) [Line Items]              
Stockholders' Equity, Reverse Stock Split   1-for-0.625          
Stockholders' Equity Note, Stock Split, Conversion Ratio   0.625          
Cash and Cash Equivalents, at Carrying Value       $ 61,240 $ 425,302 $ 208,821 $ 0
Advertising Expense       0 0    
Research and Development Expense       $ 0 $ 0    
Shares of CLS Holdings USA, Inc. [Member] | CLS Labs, Inc. [Member]              
Note 1 - Nature of Business and Significant Accounting Policies (Details) [Line Items]              
Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions (in Shares) | shares   6,250,000 10,000,000        
Equity Method Investment, Ownership Percentage     55.60%        
Computer Equipment [Member]              
Note 1 - Nature of Business and Significant Accounting Policies (Details) [Line Items]              
Property, Plant and Equipment, Useful Life       3 years      
Reverse Merger with CLS Labs [Member]              
Note 1 - Nature of Business and Significant Accounting Policies (Details) [Line Items]              
Stock Issued During Period, Shares, New Issues (in Shares) | shares 15,000,000